Skip to content

Psychiatry and Clinical Neurosciences Reports

ISSN 2769-2558

13 papers in the library · 54 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Efficacy and safety of ketamine for post‐traumatic stress disorder: A systematic review with narrative synthesis and consideration of military and veteran populations

Psychiatry and Clinical Neurosciences Reports October 7, 2026 Mary Ivasyutyn, Saajan Bhakta

Abstract Post‐traumatic stress disorder (PTSD) is a debilitating disorder with limited pharmaceutical treatment options. Ketamine, a noncompetitive N ‐methyl‐ d ‐aspartate (NMDA) receptor antagonist with rapid‐onset effects, has emerged as a potential treatment, particularly for patients who do not respond to first‐line therapies. This systematic review synthesizes the current evidence on the...

Demographic characteristics and psychosocial backgrounds of patients with dextromethorphan overdose in Japan: A multicenter prospective observational study

Psychiatry and Clinical Neurosciences Reports September 1, 2026 Hironori Katsuki, Yoshito Kamijo, Michiko Takai et al.

Abstract: Aim: Few studies in Japan have described young patients presenting to emergency departments after dextromethorphan overdose in detail. Therefore, we aimed to investigate the demographic characteristics and psychosocial backgrounds of patients who presented to emergency departments in Japan after dextromethorphan overdose. Methods: This was a multicenter, prospective, observational...

Psychosis induced by invocation presenting as possession state: A case of Kitousei-Seishinbyo still emerging in modern Japan.

Psychiatry and Clinical Neurosciences Reports December 1, 2025 Fumiya Miyano, Nobuyuki Mitsui, Yutaka Fujii et al.

Kitousei-Seishinbyo, or psychosis induced by invocation, was first described by Morita in 1915 as a culture-bound syndrome characterized by possession-like states and personality transformation triggered by prayer or spiritual practices. New psychosocial triggers (e.g., self-improvement seminars, emerging religious groups) have been identified. However, reports of possession-related episodes...

DOI: 10.1002/pcn5.70227 (opens in new tab) Full text (opens in new tab) Kitousei‐seishinbyo Culture‐bound syndromes Dissociative disorders Psychotic disorders

A sense of being inserted by the original self: A distinctive manifestation of delusional misidentification of the self, a case report.

Psychiatry and Clinical Neurosciences Reports December 1, 2025 Akihiro Koreki, Masataka Kaji, Hiroki Oi et al.

Delusional misidentification of the self is a rare psychotic symptom in which individuals misidentify themselves. These symptoms are sometimes accompanied by psychotic renaming, reflecting profound psychological changes in the self. To date, such symptoms have not been fully understood through the lens of the minimal self, especially with respect to the sense of agency (SoA). We report the case...

DOI: 10.1002/pcn5.70251 (opens in new tab) Full text (opens in new tab) Agency Delusional misidentification Ownership Self

Comparative efficacy and safety of intravenous racemic ketamine, repetitive transcranial magnetic stimulation and electroconvulsive therapy for Stage 2 or higher treatment-resistant depression: A systematic review and network meta-analysis.

Psychiatry and Clinical Neurosciences Reports September 1, 2025 Itsuki Terao, Takahiro Tsuge, Tomoo Sato et al. 2 citations

Although electroconvulsive therapy (ECT) is the standard treatment for Stage 2 or higher treatment-resistant depression, it has several drawbacks. Repetitive transcranial magnetic stimulation (rTMS) and intravenous racemic ketamine (IV ketamine) have emerged as potential alternatives, but their comparative effectiveness and safety remain unclear due to limited evidence. We systematically...

DOI: 10.1002/pcn5.70136 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Network meta‐analysis Transcranial magnetic stimulation Treatment resistance +2

Anhedonia: Current and future treatments

Psychiatry and Clinical Neurosciences Reports March 1, 2025 Alessandro Serretti 11 citations

Abstract Anhedonia is a transdiagnostic domain that leads to poor disorder outcome and low remission rates. This narrative review describes a broad range of interventions targeting anhedonia, including pharmacological, neuromodulatory, behavioral, and lifestyle‐based approaches. Drugs such as vortioxetine, agomelatine, bupropion, ketamine, and brexpiprazole show promising anti‐anhedonic...

DOI: 10.1002/pcn5.70088 (opens in new tab) Anhedonia Brain stimulation Vagus nerve stimulation Neuromodulation +5

Psychosis and suicide attempt following a single use of delta-9-tetrahydrocannabiphorol: A case report.

Psychiatry and Clinical Neurosciences Reports March 1, 2025 Daniel Greer, Jennifer Atherton, Justina Girgis

Delta-9-tetrahydrocannabiphorol (Δ9-THCP) is a potent phytocannabinoid found naturally in the cannabis plant in small quantities. This cannabinoid is noted to potently bind to cannabinoid receptor 1 and cannabinoid receptor 2 and is reported to be highly psychoactive. A small amount of Δ9-THCP is found naturally, which led to its isolation and synthetic production. This isolate is beginning to...

DOI: 10.1002/pcn5.70060 (opens in new tab) Full text (opens in new tab) Thcp Psychosis Substance use Suicidality +1

Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials

Psychiatry and Clinical Neurosciences Reports December 1, 2024 Itsuki Terao, Wakako Kodama

Abstract The individual efficacy and safety of intravenous racemic (IV) ketamine, psilocybin, and theta burst stimulation (TBS) for major depressive disorder have been demonstrated through meta‐analyses of randomized controlled trials (RCTs), but the comparative usefulness of these novel treatments has not yet been fully examined. We systematically searched the CENTRAL, Medline, CINHAL, and...

Concomitant use of dextromethorphan and alcohol-induced dissociation in a patient with alcohol dependence.

Psychiatry and Clinical Neurosciences Reports December 1, 2024 Yasuhito Nagai, Yuko Tajima, Koichi Miyakawa

Dextromethorphan (DXM) is an over-the-counter drug that is commonly abused by teenagers. Its main pharmacological property is a low-affinity N-methyl-d-aspartate (NMDA) receptor antagonist. We report acute psychotic dissociation induced by DXM and alcohol in a patient with alcohol dependence, which made it difficult to distinguish alcohol withdrawal symptoms with limited information. The...

DOI: 10.1002/pcn5.70011 (opens in new tab) Full text (opens in new tab) Alcohol dependence Dextromethorphan Over‐the‐counter otc drug

Exploring perinatal ketamine for postpartum depression following cesarean section: A systematic review.

Psychiatry and Clinical Neurosciences Reports September 1, 2024 Jaylyn Thompson, David F Lo, Alexis Foschini et al. 1 citation

The aim of this study was to explore the use of perinatal ketamine to see if it can be used for the reduction of postpartum depression (PPD) following cesarean section (C-section). PubMed, Cochrane, and Web of Science were the primary databases used for this review. Search terms used on January 5, 2024 incorporated "ketamine," "C-section," "postpartum depression," and related synonyms. The...

DOI: 10.1002/pcn5.70004 (opens in new tab) Full text (opens in new tab) Perinatal ketamine Postpartum depression ppd Postnatal depression Cesarean section c-section +2

Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens

Psychiatry and Clinical Neurosciences Reports May 16, 2024 Shunichiro Ikeda, Toshihiko Kinoshita

During the 1960s, several studies were conducted to test the therapeutic effects of hallucinogenic drugs, also known as psychedelics, on various disorders, such as major depressive disorder (MDD). However, the non-medical use of these substances became rampant due to their hallucinogenic effects, leading to their classification as narcotics in numerous countries by the 1970s. Since the 1990s,...

DOI: 10.1002/pcn5.196 (opens in new tab) Psilocybin The renaissance Hallucinogen Focus optics +1

Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.

Psychiatry and Clinical Neurosciences Reports December 1, 2023 Simon Ruffell, Max Crosland-Wood, Rob Palmer et al. 37 citations

Ayahuasca is a psychedelic plant brew originating from the Amazon rainforest. It is formed from two basic components, the Banisteriopsis caapi vine and a plant containing the potent psychedelic dimethyltryptamine (DMT), usually Psychotria viridis. Here we review the history of ayahuasca and describe recent work on its pharmacology, phenomenological responses, and clinical applications. There...

Impact of continued mindfulness practice on resilience and well-being in mindfulness-based intervention graduates during the COVID-19 pandemic: A cross-sectional study.

Psychiatry and Clinical Neurosciences Reports September 1, 2023 Chisato Tanaka, Kenta Wakaizumi, Akira Ninomiya et al. 3 citations

The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented stress. Mindfulness-based interventions (MBIs) are known to be effective in reducing stress. However, it is unclear how long-term outcomes differ between those who continue mindfulness practice after MBIs and those who do not. In this study, we hypothesized that those who continued mindfulness practice would have higher...